948 related articles for article (PubMed ID: 9384699)
21. Potentiation of interferon induction of class I major histocompatibility complex antigen expression by human tumor necrosis factor in small cell lung cancer cell lines.
Marley GM; Doyle LA; Ordóñez JV; Sisk A; Hussain A; Yen RW
Cancer Res; 1989 Nov; 49(22):6232-6. PubMed ID: 2553249
[TBL] [Abstract][Full Text] [Related]
22. Ethanol inhibits prolactin- and tumor necrosis factor-alpha-, but not gamma interferon-induced expression of intercellular adhesion molecule-1 in human astrocytoma cells.
DeVito WJ; Stone S; Mori K; Shamgochian M
J Cell Biochem; 2000 Apr; 77(3):455-64. PubMed ID: 10760953
[TBL] [Abstract][Full Text] [Related]
23. Absence of class II-associated invariant chain peptide on leukemic blasts of patients promotes activation of autologous leukemia-reactive CD4+ T cells.
van Luijn MM; van den Ancker W; Chamuleau ME; Zevenbergen A; Westers TM; Ossenkoppele GJ; van Ham SM; van de Loosdrecht AA
Cancer Res; 2011 Apr; 71(7):2507-17. PubMed ID: 21310823
[TBL] [Abstract][Full Text] [Related]
24. Induction of HLA class II antigens in osteosarcoma cells by interferons and tumor necrosis factor alpha.
Scotlandi K; Baldini N; Campanacci M; Lollini PL; Picci P; Serra M
Anticancer Res; 1992; 12(3):767-72. PubMed ID: 1622136
[TBL] [Abstract][Full Text] [Related]
25. MHC class II antigen expression in human vascular smooth muscle cells is induced by interferon-gamma and modulated by tumour necrosis factor and lymphotoxin.
Stemme S; Fager G; Hansson GK
Immunology; 1990 Feb; 69(2):243-9. PubMed ID: 2106484
[TBL] [Abstract][Full Text] [Related]
26. Regulation of MHC class II antigen expression. Opposing effects of tumor necrosis factor-alpha on IFN-gamma-induced HLA-DR and Ia expression depends on the maturation and differentiation stage of the cell.
Watanabe Y; Jacob CO
J Immunol; 1991 Feb; 146(3):899-905. PubMed ID: 1899098
[TBL] [Abstract][Full Text] [Related]
27. High expression of costimulatory molecules correlates with low relapse-free survival probability in acute myeloid leukemia (AML).
Graf M; Reif S; Hecht K; Pelka-Fleischer R; Kroell T; Pfister K; Schmetzer H
Ann Hematol; 2005 May; 84(5):287-97. PubMed ID: 15592672
[TBL] [Abstract][Full Text] [Related]
28. Cytokine modulation of human corneal epithelial cell ICAM-1 (CD54) expression.
Yannariello-brown J; Hallberg CK; Häberle H; Brysk MM; Jiang Z; Patel JA; Ernst PB; Trocme SD
Exp Eye Res; 1998 Oct; 67(4):383-93. PubMed ID: 9820785
[TBL] [Abstract][Full Text] [Related]
29. Strong expression of CD40, CD54 and HLA-DR antigen and lack of evidence for direct cellular cytotoxicity are unique immunohistopathological features in alopecia areata.
Sato-Kawamura M; Aiba S; Tagami H
Arch Dermatol Res; 2003 Mar; 294(12):536-43. PubMed ID: 12624779
[TBL] [Abstract][Full Text] [Related]
30. Apoptosis-independent retinoblastoma protein rescue of HLA class II messenger RNA IFN-gamma inducibility in non-small cell lung carcinoma cells. Lack of surface class II expression associated with a specific defect in HLA-DRA induction.
Lu Y; Boss JM; Hu SX; Xu HJ; Blanck G
J Immunol; 1996 Apr; 156(7):2495-502. PubMed ID: 8786310
[TBL] [Abstract][Full Text] [Related]
31. Human myoblasts as antigen-presenting cells.
Goebels N; Michaelis D; Wekerle H; Hohlfeld R
J Immunol; 1992 Jul; 149(2):661-7. PubMed ID: 1352532
[TBL] [Abstract][Full Text] [Related]
32. Production of tumor necrosis factor-alpha and interferon-gamma from human peripheral blood lymphocytes by MGN-3, a modified arabinoxylan from rice bran, and its synergy with interleukin-2 in vitro.
Ghoneum M; Jewett A
Cancer Detect Prev; 2000; 24(4):314-24. PubMed ID: 11059563
[TBL] [Abstract][Full Text] [Related]
33. IFN-gamma-stimulated enhancement of MHC class II antigen expression by the human mast cell line HMC-1.
Love KS; Lakshmanan RR; Butterfield JH; Fox CC
Cell Immunol; 1996 May; 170(1):85-90. PubMed ID: 8660803
[TBL] [Abstract][Full Text] [Related]
34. IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonist effects with IFN-gamma and TNF-alpha.
Albanesi C; Cavani A; Girolomoni G
J Immunol; 1999 Jan; 162(1):494-502. PubMed ID: 9886425
[TBL] [Abstract][Full Text] [Related]
35. Induction and function of eosinophil intercellular adhesion molecule-1 and HLA-DR.
Hansel TT; De Vries IJ; Carballido JM; Braun RK; Carballido-Perrig N; Rihs S; Blaser K; Walker C
J Immunol; 1992 Sep; 149(6):2130-6. PubMed ID: 1355503
[TBL] [Abstract][Full Text] [Related]
36. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
Lu C; Hassan HT
Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
[TBL] [Abstract][Full Text] [Related]
37. Modulation of Apo-1/Fas (CD95)-induced programmed cell death in myeloma cells by interferon-alpha 2.
Egle A; Villunger A; Kos M; Böck G; Gruber J; Auer B; Greil R
Eur J Immunol; 1996 Dec; 26(12):3119-26. PubMed ID: 8977313
[TBL] [Abstract][Full Text] [Related]
38. Tumor necrosis factor synergistically acts with IFN-gamma to regulate Ly-6A/E expression in T lymphocytes, thymocytes and bone marrow cells.
Malek TR; Danis KM; Codias EK
J Immunol; 1989 Mar; 142(6):1929-36. PubMed ID: 2493502
[TBL] [Abstract][Full Text] [Related]
39. The combination of gamma-interferon and tumor necrosis factor causes a rapid and extensive differentiation of human neuroblastoma cells.
Ponzoni M; Casalaro A; Lanciotti M; Montaldo PG; Cornaglia-Ferraris P
Cancer Res; 1992 Feb; 52(4):931-9. PubMed ID: 1371090
[TBL] [Abstract][Full Text] [Related]
40. Apoptosis of cultured mouse luteal cells induced by tumor necrosis factor-alpha and interferon-gamma.
Jo T; Tomiyama T; Ohashi K; Saji F; Tanizawa O; Ozaki M; Yamamoto R; Yamamoto T; Nishizawa Y; Terada N
Anat Rec; 1995 Jan; 241(1):70-6. PubMed ID: 7879925
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
